Global Injectable
Drug Delivery Market, by Device Type (Prefilled Syringes, Autoinjectors,
Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), by
Material Type (Glass and Plastic), by Usability (Disposable and Reusable), by
Route of Administration (Intravenous, Intramuscular, and Subcutaneous), by End
User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and
Others), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) was valued at US$
15,939.0 million in 2017, and is projected to exhibit a CAGR of 8.3%
over the forecast period (2018 – 2026), as highlighted in a new report
published by Coherent Market Insights.
Increasing product approval and
launch by market players to augment the market growth
Key players in the market are
focused on development of product and approval from regulatory authorities, in
order to cater to the demands of patient diagnosed with chronic diseases. For
instance, in October, 2018, Genentech announced the U.S. Food and Drug
Administration (FDA) approval for single-dose prefilled syringes (PFS) for
Xolair (omalizumab) as an additional formulation for both allergic asthma and
chronic idiopathic urticaria (CIU) indications.
Similarly, in August 2018, a new
diabetes autoinjector pen by AstraZeneca- Bydureon Bcise was approved by
European Commission, thereby offering additional treatment options for patients
with type-2 diabetes. Moreover, the market players are focused on increasing production
capacity and facility launch to expand their offerings and services, which is
expected to boost the market growth. For instance, in March 2019, Gerresheimer
AG announced to build a new plant at North Macedonia, Europe to produce
pharmaceutical plastic systems and prefillable syringes for the pharmaceutical
industry and the medical technology sector. Furthermore, increasing awareness
regarding safety and concern for needlestick injuries is a major factor driving
the global injectable drug delivery market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2768
According to the Health
Protection Agency (HPA) report in 2012, injuries among medical and dental
professionals while treating patients increased by 131% (100-231) from 2002 to
2011.
Browse 38 Market Data Tables and
32 Figures spread through 262 Pages and in-depth TOC on ‘Injectable Drug
Delivery Market’- Global Forecast to 2026, by Device Type (Prefilled Syringes,
Auto Injectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and
Others), by Material Type (Glass and Plastic), by Usability (Disposable and
Reusable), by Route of Administration (Intravenous, Intramuscular, and
Subcutaneous), by End User (Hospitals, Clinics, Ambulatory Surgical Centers,
Home Care Settings, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa)
Key players in the market are
focused on adopting strategies such as collaborations and acquisitions to
enhance their service offerings. For instance, in December 2016, SMC Ltd.
acquired Oval Medical Technologies Ltd. to expand its drug delivery
capabilities and product offerings to pharmaceutical manufacturers. Similarly,
in December 2017, Numedico Technologies signed an agreement with Mana Medical
Services. According to agreement, the latter will distribute ClickZip Needle
Retractable Safety Syringe in New Zealand and Australia.
Key Takeaways of the Global
Injectable Drug Delivery Market:
The global injectable drug
delivery market is expected to exhibit a CAGR of 8.3% over the forecast period,
owing to the product launch by the market players. For instance, in 2018,
AbbVie GK and Eisai Co., Ltd. launched an autoinjection delivery system for
HUMIRA for Subcutaneous Injection 40 mg Pen 0.4 mL and 80 mg Pen 0.8 mL.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/injectable-drug-delivery-market-2768
Among material type, the plastic
segment held a dominant position in the global injectable drug delivery market
in 2018, owing to launch of plastic syringes and cartridges. For instance, in
June 2016, Gerresheimer launched Gx RTF ClearJect, a prefillable plastic
syringe with integrated cannula, which is made from high-performance cyclo
olefin polymer (COP) plastic for sensitive medications and high-viscosity
agents.
Among usability, the disposable
segment held dominant position in the global injectable drug delivery market in
2018, owing to significant increase in self-administration to treat chronic
diseases
Among route of administration,
the subcutaneous segment held a dominant position in the global injectable drug
delivery market in 2018, as pens and auto-injectors are mainly used for
subcutaneous delivery of biopharmaceuticals, mainly for self-administrating
Among end user type, homecare
settings segment held a dominant position in the globl injectable drug delivery
market in 2018, owing to cost-effective and reliable home-based care for
treating chronic conditions
Key players operating in the
global injectable drug delivery market include, Becton, Dickinson and Company,
Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo
Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford
Limited, Injex Pharma GmbH
Buy-Now research
report: https://www.coherentmarketinsights.com/insight/buy-now/2768
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200 Seattle,
WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment